Literature DB >> 18057355

Medium- and long-term performance of 11,516 uncemented primary femoral stems from the Norwegian arthroplasty register.

G Hallan1, S A Lie, O Furnes, L B Engesaeter, S E Vollset, L I Havelin.   

Abstract

Primary uncemented femoral stems reported to the Norwegian arthroplasty register between 1987 and 2005 were included in this prospective observational study. There were 11 516 hips (9679 patients) and 14 different designs of stem. Kaplan-Meier survival probabilities and Cox regression were used to analyse the data. With aseptic loosening as the end-point, all currently used designs performed excellently with survival of 96% to 100% at ten years. With the end-point as stem revision for any cause, the long-term results of the different designs varied from poor to excellent, with survival at 15 years ranging between 29% and 97%. Follow-up for longer than seven years was needed to identify some of the poorly-performing designs. There were differences between the stems; the Corail, used in 5456 hips, was the most frequently used stem with a survival of 97% at 15 years. Male gender was associated with an increased risk of revision of x 1.3 (95% confidence interval 1.05 to 1.52), but age and diagnosis had no influence on the results. Overall, modern uncemented femoral stems performed well. Moderate differences in survival between well-performing stems should be interpreted with caution since the differences may be caused by factors other than the stem itself.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057355     DOI: 10.1302/0301-620X.89B12.18969

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  59 in total

1.  Survival of the cementless Spotorno stem in the second decade.

Authors:  Peter R Aldinger; Alexander W Jung; Steffen J Breusch; Volker Ewerbeck; Dominik Parsch
Journal:  Clin Orthop Relat Res       Date:  2009-06-06       Impact factor: 4.176

2.  Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures.

Authors:  Wender Figved; Vidar Opland; Frede Frihagen; Tore Jervidalo; Jan Erik Madsen; Lars Nordsletten
Journal:  Clin Orthop Relat Res       Date:  2009-01-07       Impact factor: 4.176

3.  Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: 5-year followup of a randomized trial.

Authors:  Ellen Langslet; Frede Frihagen; Vidar Opland; Jan Erik Madsen; Lars Nordsletten; Wender Figved
Journal:  Clin Orthop Relat Res       Date:  2013-10-01       Impact factor: 4.176

4.  THA with the ABG I prosthesis at 15 years. Excellent survival with minimal osteolysis.

Authors:  P N Baker; I A McMurtry; G Chuter; A Port; J Anderson
Journal:  Clin Orthop Relat Res       Date:  2010-07       Impact factor: 4.176

5.  Primary total hip arthroplasty with dual mobility socket to prevent dislocation: a 22-year follow-up of 240 hips.

Authors:  Bertrand Boyer; Rémi Philippot; Jean Geringer; Frédéric Farizon
Journal:  Int Orthop       Date:  2011-06-23       Impact factor: 3.075

6.  Surgical Revision after Sacroiliac Joint Fixation or Fusion.

Authors:  Katie Spain; Timothy Holt
Journal:  Int J Spine Surg       Date:  2017-01-19

7.  Understanding wear in dual mobility total hip replacement: first generation explant wear patterns.

Authors:  Bertrand Boyer; Thomas Neri; Jean Geringer; Alexandre Di Iorio; Remi Philippot; Frederic Farizon
Journal:  Int Orthop       Date:  2016-12-07       Impact factor: 3.075

8.  Early migration characteristics of a hydroxyapatite-coated femoral stem: an RSA study.

Authors:  David Campbell; Graham Mercer; Kjell G Nilsson; Vanessa Wells; John R Field; Stuart A Callary
Journal:  Int Orthop       Date:  2009-12-13       Impact factor: 3.075

9.  Hip resurfacing data from national joint registries: what do they tell us? What do they not tell us?

Authors:  Kristoff Corten; Steven J MacDonald
Journal:  Clin Orthop Relat Res       Date:  2010-02       Impact factor: 4.176

10.  Uncemented custom femoral components in hip arthroplasty. A prospective clinical study of 191 hips followed for at least 7 years.

Authors:  Pål Benum; Arild Aamodt
Journal:  Acta Orthop       Date:  2010-08       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.